Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The American Diabetes Association recommends individuals with type 1 diabetes (T1D) adjust insulin for dietary fat; however, optimal adjustments are not known. This study aimed to determine 1) the relationship between the amount and type of dietary fat and glycemia and 2) the optimal insulin adjustments for dietary fat. RESEARCH DESIGN AND METHODS: Adults with T1D using insulin pump therapy attended the research clinic on 9–12 occasions. On the first six visits, participants consumed meals containing 45 g carbohydrate with 0 g, 20 g, 40 g, or 60 g fat and either saturated, monounsaturated, or polyunsaturated fat. Insulin was dosed using individual insulin/carbohydrate ratio as a dual-wave 50/50% over 2 h. On subsequent visits, participants repeated the 20–60-g fat meals with the insulin dose estimated using a model predictive bolus, up to twice per meal, until glycemic control was achieved. RESULTS: With the same insulin dose, increasing the amount of fat resulted in a significant dose-dependent reduction in incremental area under the curve for glucose (iAUCglucose) in the early postprandial period (0–2 h; P = 0.008) and increase in iAUCglucose in the late postprandial period (2–5 h; P = 0.004). The type of fat made no significant difference to the 5-h iAUCglucose. To achieve glycemic control, on average participants required dual-wave insulin bolus: for 20 g fat, +6% insulin, 74/26% over 73 min; 40 g fat, +6% insulin, 63/37% over 75 min; and 60 g fat, +21% insulin, 49/51% over 105 min. CONCLUSIONS: This study provides clinical guidance for mealtime insulin dosing recommendations for dietary fat in T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s009 · Cited by 739
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460 · cited 1×
“The metabolic models used are well-established models describing insulin pharmacokinetic/pharmacodynamics (13) (Bergman minimal model [14] and a two-compartment model describing rate of glucose appearance following a meal”
MethodBell, K. J., Smart, C. E., Steil, G. M., Brand-Miller, J. C., King, B., & Wolpert, H. A. (2015) · Diabetes Care · doi:10.2337/dc15-0100 · Cited by 390
Self-citationSimulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Wilinska, M. E., Chassin, L. J., Acerini, C. L., Allen, J. M., Dunger, D. B., & Hovorka, R. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400117 · Cited by 244
Smart, C. E. M., Evans, M., O’Connell, S. M., McElduff, P., Lopez, P. E., Jones, T. W., Davis, E. A., & King, B. R. (2013) · Diabetes Care · doi:10.2337/dc13-1195 · Cited by 240 · cited 2×
“in children and adolescents and that insulin doses need to be increased by a similar proportion (4,5), current findings need to be verified in this population.”
BackgroundLeung, G. K. W., Huggins, C. E., & Bonham, M. P. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.11.010 · Cited by 132 · cited 2×
“[n (%)] 2 (17) 2 (17) 1 (8) 0 (0) 0 (0) 0 (0) d .”
BackgroundBell, K. J., Toschi, E., Steil, G. M., & Wolpert, H. A. (2016) · Diabetes Care · doi:10.2337/dc15-2855 · Cited by 121
Self-citationPaterson, M. A., Smart, C. E. M., Lopez, P. E., McElduff, P., Attia, J., Morbey, C., & King, B. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13011 · Cited by 111 · cited 1×
“(19) have previously investigated the dose-response relationship between protein and glycemia, but the glycemic impact of varying the type of protein and the corresponding optimal insulin adjustments for protein remain unknown.”
BackgroundCampbell, M. D., Walker, M., King, D., Gonzalez, J. T., Allerton, D., Stevenson, E. J., Shaw, J. A., & West, D. J. (2016) · Diabetes Care · doi:10.2337/dc16-0709 · Cited by 32 · cited 2×
“Incidence of hypoglycemia [n (%)] 5 (29) 3 (18) 3 (18) 0.”
Background
Cited by
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
Metwally, M., Cheung, T. O., Smith, R., & Bell, K. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108516 · Cited by 29
Metadata
- Authors
- Bell, K. J., Fio, C. Z., Twigg, S., Duke, S.-A., Fulcher, G., Alexander, K., McGill, M., Wong, J., Brand-Miller, J., & Steil, G. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-08-27
- Volume
- 43
- Issue
- 1
- Pages
- 59-66
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2970749203
- Cited by
- 62
- References
- 9
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.